Compare VIR & ENR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIR | ENR |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.2B |
| IPO Year | 2019 | 2015 |
| Metric | VIR | ENR |
|---|---|---|
| Price | $10.35 | $19.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $19.63 | ★ $23.57 |
| AVG Volume (30 Days) | ★ 1.9M | 1.0M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.23% |
| EPS Growth | 17.49 | ★ 538.46 |
| EPS | N/A | ★ 3.32 |
| Revenue | $68,556,000.00 | ★ $2,952,700,000.00 |
| Revenue This Year | $270.22 | $4.51 |
| Revenue Next Year | N/A | $1.07 |
| P/E Ratio | ★ N/A | $5.81 |
| Revenue Growth | N/A | ★ 2.28 |
| 52 Week Low | $4.16 | $16.00 |
| 52 Week High | $10.91 | $30.29 |
| Indicator | VIR | ENR |
|---|---|---|
| Relative Strength Index (RSI) | 64.41 | 64.66 |
| Support Level | $5.14 | $19.45 |
| Resistance Level | $10.91 | $20.50 |
| Average True Range (ATR) | 0.48 | 0.63 |
| MACD | 0.12 | 0.45 |
| Stochastic Oscillator | 89.74 | 97.54 |
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
Energizer Holdings Inc. manufactures and distributes household batteries, specialty batteries, and lighting products. The company offers batteries using lithium, alkaline, carbon zinc, nickel metal hydride, zinc air, and silver oxide technologies, sold under the Energizer, Rayovac, Varta, and Eveready brands across performance and premium price segments. It also provides auto care products in the appearance, fragrance, performance, and air conditioning recharge categories. Energizer operates through two geographical segments, the United States and International, with the majority of its revenue generated in the United States. It has two product segments: Batteries and Lights and Auto Care, with the Batteries and Lights segment contributing the majority of its revenue.